Teva Pharmaceutical Industries (NYSE:TEVA)

Top Analyst Upgrades and Downgrades: Allergan, Costco, Cree, Dollar Tree, Eli Lilly, FedEx, Mylan, NextEra, Peabody, Teva, Yum Brands and More

Posted: March 20, 2019 at 8:55 am

Stocks were indicated to open marginally higher on Wednesday ahead of the FOMC decision on interest rates. With the market having recouped so much ground in 2019, investors need to ...
Read Full Story »

Big Pharma Short Interest Backs Off, With One Huge Exception

Posted: March 12, 2019 at 8:35 am

Pharmaceutical companies usually are involved in a lengthy process of getting their drug candidates to market through clinical trials. There is a fair amount of risk involved, should a study ...
Read Full Story »

Flop City: 7 Big Stocks Completely Overlooked by the 10-Year Bull Market

Posted: March 11, 2019 at 11:50 am

The current bull market is now officially 10 years old. That anniversary took place on Saturday, March 9. The Great Recession was the worst modern-era recession, and it was followed ...
Read Full Story »

Top Analyst Upgrades and Downgrades: CSX, Intelsat, Kohl’s, NIO, Rio Tinto, TripAdvisor, VMware and More

Posted: March 6, 2019 at 8:40 am

Stocks were indicated to open marginally lower on Wednesday after Tuesday's sell-off. After the Dow Jones industrials had initially risen well over 3,000 points from its lows in January, investors ...
Read Full Story »

Major Pharma Sees Tremendous Rise in Short Interest

Posted: February 28, 2019 at 8:30 am

Pharmaceutical companies usually are involved in a lengthy process of getting their drug candidates to market through clinical trials. There is a fair amount of risk involved, should a study ...
Read Full Story »

Top Analyst Upgrades and Downgrades: CenturyLink, Chimera, Comerica, Dish, Exxon, NetApp, Pulte, Petrobras, Teva, Yelp and More

Posted: February 14, 2019 at 8:58 am

Stocks were indicated to open marginally higher again on Thursday, but the Dow Jones industrial average is now up over 2,700 points from its lows seen at the start of ...
Read Full Story »

What Held Back Teva in Q4

Posted: February 13, 2019 at 9:15 am

Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) released its fourth-quarter financial results before the markets opened on Wednesday. The pharma giant said that it had $0.53 in earnings per share (EPS) ...
Read Full Story »

Major Pharma Scares Off Short Sellers

Posted: February 12, 2019 at 9:35 am

Pharmaceutical companies usually are involved in a lengthy process of getting their drug candidates to market through clinical trials. There is a fair amount of risk involved, should a study ...
Read Full Story »

Nvidia, Cisco, Under Armour and More Major Earnings Coming This Week

Posted: February 10, 2019 at 9:55 am

The broad markets ended the past week on a negative note, after coming off of an incredible rally in January. Although many companies ended the week with solid gains from ...
Read Full Story »

Short Interest Spikes in a Couple Major Pharma Stocks

Posted: January 28, 2019 at 10:10 am

Pharmaceutical companies usually are involved in a lengthy process of getting their drug candidates to market through clinical trials. There is a fair amount of risk involved, should a study ...
Read Full Story »

Top Analyst Upgrades and Downgrades: Alphabet, Amazon, Dell, IBM, International Paper, Merck, Pfizer, Tesla, Teva, Walmart and More

Posted: January 23, 2019 at 8:50 am

Stocks had traded lower on Tuesday, but Wednesday's early indications were to recover about half of those prior losses. After so much volatility, investors should be rethinking and considering how ...
Read Full Story »

Major Pharma Sees Fading Short Interest

Posted: January 11, 2019 at 9:50 am

Pharmaceutical companies usually are involved in a lengthy process of getting their drug candidates to market through clinical trials. There is a fair amount of risk involved, should a study ...
Read Full Story »

Teva and Amgen Settle Over Kidney Disease Patent Infringement

Posted: January 3, 2019 at 1:25 pm

Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) announced on Thursday that it has settled with Amgen Inc. (NASDAQ: AMGN) for its treatment of secondary hyperparathyroidism (HPT) in adult patients with chronic kidney ...
Read Full Story »

Top Analyst Upgrades and Downgrades: AbbVie, Agilent, Albermarle, Apple, Boeing, Cheniere, First Solar, HCA, LabCorp, Lumber Liquidators, Teva and More

Posted: January 3, 2019 at 9:15 am

Stocks started 2019 on a mixed playing field on Wednesday, but Apple dropped a revenue and earnings warning after the close and that sent equity index futures down over 1% ...
Read Full Story »

Short Sellers Hike Bets in Major Pharma Stocks

Posted: December 27, 2018 at 10:00 am

Pharmaceutical companies usually are involved in a lengthy process of getting their drug candidates to market through clinical trials. There is a fair amount of risk involved, should a study ...
Read Full Story »